{"id":7920,"date":"2024-02-12T13:24:47","date_gmt":"2024-02-12T12:24:47","guid":{"rendered":"https:\/\/www.iqac.csic.es\/xna-hub-platform-to-boost-therapeutic-modified-oligonucleotides\/"},"modified":"2026-06-16T11:11:19","modified_gmt":"2026-06-16T09:11:19","slug":"xna-hub-platform-to-boost-therapeutic-modified-oligonucleotides","status":"publish","type":"post","link":"https:\/\/www.iqac.csic.es\/en\/xna-hub-platform-to-boost-therapeutic-modified-oligonucleotides\/","title":{"rendered":"XNA-HUB, platform to boost therapeutic modified oligonucleotides"},"content":{"rendered":"<p>The creation of the <strong>XNA-HUB platform<\/strong> involves a multidisciplinary consortium composed of the company <a href=\"https:\/\/www.nostrumbiodiscovery.com\/\" target=\"_blank\" rel=\"noopener\"><strong>Nostrum Biodiscovery<\/strong><\/a>, a joint spin-off of the <a href=\"https:\/\/www.bsc.es\/\" target=\"_blank\" rel=\"noopener\"><strong>Barcelona Supercomputing Center<\/strong><\/a> and the <a href=\"https:\/\/www.irbbarcelona.org\/es\" target=\"_blank\" rel=\"noopener\"><strong>IRB Barcelona<\/strong><\/a>; the <a href=\"https:\/\/www.iqac.csic.es\/research\/departments\/surfactants-and-nanobiotechnology\/nucleic-acids-chemistry\/\" target=\"_blank\" rel=\"noopener\">Nucleic Acid Chemistry<\/a> group of the <a href=\"https:\/\/www.iqac.csic.es\/\" target=\"_blank\" rel=\"noopener\"><strong>Institute for Advanced Chemistry of Catalonia (IQAC-CSIC)<\/strong><\/a>; the Nucleic Acid NMR Spectroscopy group of the <a href=\"https:\/\/www.iqf.csic.es\/es\/\" target=\"_blank\" rel=\"noopener\"><strong>Blas Cabrera Institute of Physical Chemistry (IQF\u2013CSIC)<\/strong><\/a>; and the Molecular Modeling and Bioinformatics group of the <strong>IRB Barcelona<\/strong>.<\/p>\n<p>The objective is the development of innovative therapies based on chemically modified oligonucleotides (XNA, &#8220;Xeno Nucleic Acid&#8221;) to enhance their properties for drug development targeting various chronic and oncological diseases such as Alzheimer&#8217;s, diabetes, multiple sclerosis, and various types of cancer. All partners specialize in different areas involved in the drug development cycle based on oligonucleotides. This platform also aims to position Spain as a leader in the field of nucleic acids and provide valuable technological resources for the country&#8217;s growth.<\/p>\n<p>The project has been selected to receive funding as one of the Strategic Projects for Economic Recovery and Transformation (PERTE), which will be a significant boost to its development.<\/p>\n<p>Modified nucleic acids are one of the most promising pharmacological strategies at the moment. To date, the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have approved around 20 therapies based on nucleic acids. The market volume for these therapies is expected to grow at an annual rate of 13.35% until 2027, with estimated revenues of $3.9 million, according to industry sources.<\/p>\n<p>&nbsp;<\/p>\n<p><a href=\"https:\/\/rdcsic.dicat.csic.es\/en\/biologia-y-biomedicina-2\/106-projects\/717-a-platform-to-boost-therapeutic-modified-oligonucleotides\" target=\"_blank\" rel=\"noopener\"><strong>R+D article<\/strong><\/a><\/p>\n<p>&nbsp;<\/p>\n<p style=\"text-align: right;\"><strong>Communication CSIC Catalunya<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The creation of the XNA-HUB platform involves a multidisciplinary consortium composed of the company Nostrum Biodiscovery, a joint spin-off of the Barcelona Supercomputing Center and the IRB Barcelona; the Nucleic Acid Chemistry group of the Institute for Advanced Chemistry of Catalonia (IQAC-CSIC); the Nucleic Acid NMR Spectroscopy group of the Blas Cabrera Institute of Physical<a class=\"more-link\" href=\"https:\/\/www.iqac.csic.es\/en\/xna-hub-platform-to-boost-therapeutic-modified-oligonucleotides\/\">Continue reading <span class=\"screen-reader-text\">&#8220;XNA-HUB, platform to boost therapeutic modified oligonucleotides&#8221;<\/span><\/a><\/p>\n","protected":false},"author":3,"featured_media":3954,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[70],"tags":[],"class_list":["post-7920","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>XNA-HUB, platform to boost therapeutic modified oligonucleotides | IQAC - Institut de Qu\u00edmica Avan\u00e7ada de Catalunya - CSIC<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.iqac.csic.es\/en\/xna-hub-platform-to-boost-therapeutic-modified-oligonucleotides\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"XNA-HUB, platform to boost therapeutic modified oligonucleotides | IQAC - Institut de Qu\u00edmica Avan\u00e7ada de Catalunya - CSIC\" \/>\n<meta property=\"og:description\" content=\"The creation of the XNA-HUB platform involves a multidisciplinary consortium composed of the company Nostrum Biodiscovery, a joint spin-off of the Barcelona Supercomputing Center and the IRB Barcelona; the Nucleic Acid Chemistry group of the Institute for Advanced Chemistry of Catalonia (IQAC-CSIC); the Nucleic Acid NMR Spectroscopy group of the Blas Cabrera Institute of PhysicalContinue reading &quot;XNA-HUB, platform to boost therapeutic modified oligonucleotides&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.iqac.csic.es\/en\/xna-hub-platform-to-boost-therapeutic-modified-oligonucleotides\/\" \/>\n<meta property=\"og:site_name\" content=\"IQAC - Institut de Qu\u00edmica Avan\u00e7ada de Catalunya - CSIC\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/iqac.csic.es\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-02-12T12:24:47+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-16T09:11:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.iqac.csic.es\/wp-content\/uploads\/2026\/06\/XNA-HUB-Image-fondo-negro.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"900\" \/>\n\t<meta property=\"og:image:height\" content=\"533\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Ana Sotres\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@IQAC_CSIC\" \/>\n<meta name=\"twitter:site\" content=\"@IQAC_CSIC\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ana Sotres\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.iqac.csic.es\\\/en\\\/xna-hub-platform-to-boost-therapeutic-modified-oligonucleotides\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.iqac.csic.es\\\/en\\\/xna-hub-platform-to-boost-therapeutic-modified-oligonucleotides\\\/\"},\"author\":{\"name\":\"Ana Sotres\",\"@id\":\"https:\\\/\\\/www.iqac.csic.es\\\/#\\\/schema\\\/person\\\/ac65d00561d3a6d2810128c46771aff7\"},\"headline\":\"XNA-HUB, platform to boost therapeutic modified oligonucleotides\",\"datePublished\":\"2024-02-12T12:24:47+00:00\",\"dateModified\":\"2026-06-16T09:11:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.iqac.csic.es\\\/en\\\/xna-hub-platform-to-boost-therapeutic-modified-oligonucleotides\\\/\"},\"wordCount\":259,\"publisher\":{\"@id\":\"https:\\\/\\\/www.iqac.csic.es\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.iqac.csic.es\\\/en\\\/xna-hub-platform-to-boost-therapeutic-modified-oligonucleotides\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.iqac.csic.es\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/XNA-HUB-Image-fondo-negro.jpg\",\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.iqac.csic.es\\\/en\\\/xna-hub-platform-to-boost-therapeutic-modified-oligonucleotides\\\/\",\"url\":\"https:\\\/\\\/www.iqac.csic.es\\\/en\\\/xna-hub-platform-to-boost-therapeutic-modified-oligonucleotides\\\/\",\"name\":\"XNA-HUB, platform to boost therapeutic modified oligonucleotides | IQAC - Institut de Qu\u00edmica Avan\u00e7ada de Catalunya - CSIC\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.iqac.csic.es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.iqac.csic.es\\\/en\\\/xna-hub-platform-to-boost-therapeutic-modified-oligonucleotides\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.iqac.csic.es\\\/en\\\/xna-hub-platform-to-boost-therapeutic-modified-oligonucleotides\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.iqac.csic.es\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/XNA-HUB-Image-fondo-negro.jpg\",\"datePublished\":\"2024-02-12T12:24:47+00:00\",\"dateModified\":\"2026-06-16T09:11:19+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.iqac.csic.es\\\/en\\\/xna-hub-platform-to-boost-therapeutic-modified-oligonucleotides\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.iqac.csic.es\\\/en\\\/xna-hub-platform-to-boost-therapeutic-modified-oligonucleotides\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.iqac.csic.es\\\/en\\\/xna-hub-platform-to-boost-therapeutic-modified-oligonucleotides\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.iqac.csic.es\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/XNA-HUB-Image-fondo-negro.jpg\",\"contentUrl\":\"https:\\\/\\\/www.iqac.csic.es\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/XNA-HUB-Image-fondo-negro.jpg\",\"width\":900,\"height\":533},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.iqac.csic.es\\\/en\\\/xna-hub-platform-to-boost-therapeutic-modified-oligonucleotides\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/www.iqac.csic.es\\\/en\\\/home\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"XNA-HUB, platform to boost therapeutic modified oligonucleotides\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.iqac.csic.es\\\/#website\",\"url\":\"https:\\\/\\\/www.iqac.csic.es\\\/\",\"name\":\"IQAC - Institut de Qu\u00edmica Avan\u00e7ada de Catalunya - CSIC\",\"description\":\"Chemistry for a better life\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.iqac.csic.es\\\/#organization\"},\"alternateName\":\"IQAC - Institut de Qu\u00edmica Avan\u00e7ada de Catalunya - CSIC\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.iqac.csic.es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.iqac.csic.es\\\/#organization\",\"name\":\"IQAC - Institut de Qu\u00edmica Avan\u00e7ada de Catalunya - CSIC\",\"alternateName\":\"IQAC - Institut de Qu\u00edmica Avan\u00e7ada de Catalunya - CSIC\",\"url\":\"https:\\\/\\\/www.iqac.csic.es\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.iqac.csic.es\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.iqac.csic.es\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/cropped-favicon-1.png\",\"contentUrl\":\"https:\\\/\\\/www.iqac.csic.es\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/cropped-favicon-1.png\",\"width\":512,\"height\":512,\"caption\":\"IQAC - Institut de Qu\u00edmica Avan\u00e7ada de Catalunya - CSIC\"},\"image\":{\"@id\":\"https:\\\/\\\/www.iqac.csic.es\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/iqac.csic.es\\\/\",\"https:\\\/\\\/x.com\\\/IQAC_CSIC\",\"https:\\\/\\\/www.instagram.com\\\/iqac_csic\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UC1JXTOe3-s8UnYu_A6-SI3A\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/iqac-csic\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.iqac.csic.es\\\/#\\\/schema\\\/person\\\/ac65d00561d3a6d2810128c46771aff7\",\"name\":\"Ana Sotres\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/25826e5f3a7a258c44e58bdd075d81df4fb82260d2ac4db8eb7f8a34fe10b563?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/25826e5f3a7a258c44e58bdd075d81df4fb82260d2ac4db8eb7f8a34fe10b563?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/25826e5f3a7a258c44e58bdd075d81df4fb82260d2ac4db8eb7f8a34fe10b563?s=96&d=mm&r=g\",\"caption\":\"Ana Sotres\"},\"sameAs\":[\"https:\\\/\\\/www.iqac.csic.es\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"XNA-HUB, platform to boost therapeutic modified oligonucleotides | IQAC - Institut de Qu\u00edmica Avan\u00e7ada de Catalunya - CSIC","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.iqac.csic.es\/en\/xna-hub-platform-to-boost-therapeutic-modified-oligonucleotides\/","og_locale":"en_US","og_type":"article","og_title":"XNA-HUB, platform to boost therapeutic modified oligonucleotides | IQAC - Institut de Qu\u00edmica Avan\u00e7ada de Catalunya - CSIC","og_description":"The creation of the XNA-HUB platform involves a multidisciplinary consortium composed of the company Nostrum Biodiscovery, a joint spin-off of the Barcelona Supercomputing Center and the IRB Barcelona; the Nucleic Acid Chemistry group of the Institute for Advanced Chemistry of Catalonia (IQAC-CSIC); the Nucleic Acid NMR Spectroscopy group of the Blas Cabrera Institute of PhysicalContinue reading \"XNA-HUB, platform to boost therapeutic modified oligonucleotides\"","og_url":"https:\/\/www.iqac.csic.es\/en\/xna-hub-platform-to-boost-therapeutic-modified-oligonucleotides\/","og_site_name":"IQAC - Institut de Qu\u00edmica Avan\u00e7ada de Catalunya - CSIC","article_publisher":"https:\/\/www.facebook.com\/iqac.csic.es\/","article_published_time":"2024-02-12T12:24:47+00:00","article_modified_time":"2026-06-16T09:11:19+00:00","og_image":[{"width":900,"height":533,"url":"https:\/\/www.iqac.csic.es\/wp-content\/uploads\/2026\/06\/XNA-HUB-Image-fondo-negro.jpg","type":"image\/jpeg"}],"author":"Ana Sotres","twitter_card":"summary_large_image","twitter_creator":"@IQAC_CSIC","twitter_site":"@IQAC_CSIC","twitter_misc":{"Written by":"Ana Sotres","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.iqac.csic.es\/en\/xna-hub-platform-to-boost-therapeutic-modified-oligonucleotides\/#article","isPartOf":{"@id":"https:\/\/www.iqac.csic.es\/en\/xna-hub-platform-to-boost-therapeutic-modified-oligonucleotides\/"},"author":{"name":"Ana Sotres","@id":"https:\/\/www.iqac.csic.es\/#\/schema\/person\/ac65d00561d3a6d2810128c46771aff7"},"headline":"XNA-HUB, platform to boost therapeutic modified oligonucleotides","datePublished":"2024-02-12T12:24:47+00:00","dateModified":"2026-06-16T09:11:19+00:00","mainEntityOfPage":{"@id":"https:\/\/www.iqac.csic.es\/en\/xna-hub-platform-to-boost-therapeutic-modified-oligonucleotides\/"},"wordCount":259,"publisher":{"@id":"https:\/\/www.iqac.csic.es\/#organization"},"image":{"@id":"https:\/\/www.iqac.csic.es\/en\/xna-hub-platform-to-boost-therapeutic-modified-oligonucleotides\/#primaryimage"},"thumbnailUrl":"https:\/\/www.iqac.csic.es\/wp-content\/uploads\/2026\/06\/XNA-HUB-Image-fondo-negro.jpg","articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.iqac.csic.es\/en\/xna-hub-platform-to-boost-therapeutic-modified-oligonucleotides\/","url":"https:\/\/www.iqac.csic.es\/en\/xna-hub-platform-to-boost-therapeutic-modified-oligonucleotides\/","name":"XNA-HUB, platform to boost therapeutic modified oligonucleotides | IQAC - Institut de Qu\u00edmica Avan\u00e7ada de Catalunya - CSIC","isPartOf":{"@id":"https:\/\/www.iqac.csic.es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.iqac.csic.es\/en\/xna-hub-platform-to-boost-therapeutic-modified-oligonucleotides\/#primaryimage"},"image":{"@id":"https:\/\/www.iqac.csic.es\/en\/xna-hub-platform-to-boost-therapeutic-modified-oligonucleotides\/#primaryimage"},"thumbnailUrl":"https:\/\/www.iqac.csic.es\/wp-content\/uploads\/2026\/06\/XNA-HUB-Image-fondo-negro.jpg","datePublished":"2024-02-12T12:24:47+00:00","dateModified":"2026-06-16T09:11:19+00:00","breadcrumb":{"@id":"https:\/\/www.iqac.csic.es\/en\/xna-hub-platform-to-boost-therapeutic-modified-oligonucleotides\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.iqac.csic.es\/en\/xna-hub-platform-to-boost-therapeutic-modified-oligonucleotides\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.iqac.csic.es\/en\/xna-hub-platform-to-boost-therapeutic-modified-oligonucleotides\/#primaryimage","url":"https:\/\/www.iqac.csic.es\/wp-content\/uploads\/2026\/06\/XNA-HUB-Image-fondo-negro.jpg","contentUrl":"https:\/\/www.iqac.csic.es\/wp-content\/uploads\/2026\/06\/XNA-HUB-Image-fondo-negro.jpg","width":900,"height":533},{"@type":"BreadcrumbList","@id":"https:\/\/www.iqac.csic.es\/en\/xna-hub-platform-to-boost-therapeutic-modified-oligonucleotides\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/www.iqac.csic.es\/en\/home\/"},{"@type":"ListItem","position":2,"name":"XNA-HUB, platform to boost therapeutic modified oligonucleotides"}]},{"@type":"WebSite","@id":"https:\/\/www.iqac.csic.es\/#website","url":"https:\/\/www.iqac.csic.es\/","name":"IQAC - Institut de Qu\u00edmica Avan\u00e7ada de Catalunya - CSIC","description":"Chemistry for a better life","publisher":{"@id":"https:\/\/www.iqac.csic.es\/#organization"},"alternateName":"IQAC - Institut de Qu\u00edmica Avan\u00e7ada de Catalunya - CSIC","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.iqac.csic.es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.iqac.csic.es\/#organization","name":"IQAC - Institut de Qu\u00edmica Avan\u00e7ada de Catalunya - CSIC","alternateName":"IQAC - Institut de Qu\u00edmica Avan\u00e7ada de Catalunya - CSIC","url":"https:\/\/www.iqac.csic.es\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.iqac.csic.es\/#\/schema\/logo\/image\/","url":"https:\/\/www.iqac.csic.es\/wp-content\/uploads\/2025\/11\/cropped-favicon-1.png","contentUrl":"https:\/\/www.iqac.csic.es\/wp-content\/uploads\/2025\/11\/cropped-favicon-1.png","width":512,"height":512,"caption":"IQAC - Institut de Qu\u00edmica Avan\u00e7ada de Catalunya - CSIC"},"image":{"@id":"https:\/\/www.iqac.csic.es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/iqac.csic.es\/","https:\/\/x.com\/IQAC_CSIC","https:\/\/www.instagram.com\/iqac_csic","https:\/\/www.youtube.com\/channel\/UC1JXTOe3-s8UnYu_A6-SI3A","https:\/\/www.linkedin.com\/company\/iqac-csic\/"]},{"@type":"Person","@id":"https:\/\/www.iqac.csic.es\/#\/schema\/person\/ac65d00561d3a6d2810128c46771aff7","name":"Ana Sotres","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/25826e5f3a7a258c44e58bdd075d81df4fb82260d2ac4db8eb7f8a34fe10b563?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/25826e5f3a7a258c44e58bdd075d81df4fb82260d2ac4db8eb7f8a34fe10b563?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/25826e5f3a7a258c44e58bdd075d81df4fb82260d2ac4db8eb7f8a34fe10b563?s=96&d=mm&r=g","caption":"Ana Sotres"},"sameAs":["https:\/\/www.iqac.csic.es\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.iqac.csic.es\/en\/wp-json\/wp\/v2\/posts\/7920","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.iqac.csic.es\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.iqac.csic.es\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.iqac.csic.es\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.iqac.csic.es\/en\/wp-json\/wp\/v2\/comments?post=7920"}],"version-history":[{"count":1,"href":"https:\/\/www.iqac.csic.es\/en\/wp-json\/wp\/v2\/posts\/7920\/revisions"}],"predecessor-version":[{"id":8687,"href":"https:\/\/www.iqac.csic.es\/en\/wp-json\/wp\/v2\/posts\/7920\/revisions\/8687"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.iqac.csic.es\/en\/wp-json\/wp\/v2\/media\/3954"}],"wp:attachment":[{"href":"https:\/\/www.iqac.csic.es\/en\/wp-json\/wp\/v2\/media?parent=7920"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.iqac.csic.es\/en\/wp-json\/wp\/v2\/categories?post=7920"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.iqac.csic.es\/en\/wp-json\/wp\/v2\/tags?post=7920"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}